http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2227a923a75d4a3d7ba499489cf80e46
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Lubinski Jan Lubinski |
| name | Jan Lubinski |
| given-name | Jan |
| organization-name | Department of Genetics and Pathology International Hereditary Cancer Center, Pomeranian Medical University Szczecin Poland Amy P.M. Finch, Barry Rosen, Andrea Eisen, Kelly A. Metcalfe, Islay Thompson, Joan Murphy, Ping Sun, and Steven A. Narod, University of Toronto; Barry Rosen and Joan Murphy, Princess Margaret Hospital; Amy P.M. Finch, Islay Thompson, Ping Sun, and Steven A. Narod, Women's College Research Institute; Andrea Eisen, Sunnybrook Odette Cancer Center, Toronto; Peter Ainsworth, London Regional Cancer Program, London, Ontario; Parviz Ghadirian, University of Montreal Hospital Centre; William D. Foulkes, McGill... 3Department of Genetics and Pathology, International Hereditary Cancer Center, Szczecin, Poland 14International Hereditary Cancer Centre, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; International Hereditary Cancer Center, Department of Genetics and Pathology Pomeranian Medical University Szczecin Poland Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University Szczecin Poland Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands Author affiliations appear at the end of this article. 10Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia 1Department of Genetics and Pathology, Hereditary Cancer Centre, Pomeranian Academy of Medicine, Szczecin, Poland and From the Toronto-Sunnybrook Regional Cancer Center, Toronto, ON, Canada; Pomeranian Medical University, Szczecin, Poland; Daniel den Hoed Cancer Center and Erasmus University Medical Center, Rotterdam, Netherlands; Department of Cancer Genetics, Norwegian Radium Hospital, Oslo, Norway; Department of Preventive Medicine and Public Health, Creighton University School of Medicine, Omaha, NE; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY; Departments of Medicine and Genetics... 24 Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland Department of Pathology and Genetics Pomeranian Medical University Szczecin Poland Department of Genetics and Pathology Pomeranian Medical University Szczecin Poland Department of Cell Biology, Nencki Institute of Experimental Biology, Pasteura 3, 02093, Warsaw, Poland;; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Polabska 4, 70115, Szczecin, Poland Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland, 1Genetics and Pathology, International Hereditary Cancer Center and Departments of Department of Genetics and Pathology, International Hereditary Cancer Centre Pomeranian Medical University Szczecin Poland Pomeranian Medical University, Department of Genetics and Pathology, International Hereditary Cancer Center, Szczecin, Poland. Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland, Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland. From the University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh; Cancer Research United Kingdom Clinical Trials Unit, Beatson West of Scotland Cancer Centre Level 0, Glasgow; ANCHOR Unit and University of Aberdeen, Aberdeen Royal Infirmary, Foresterhill, Aberdeen; Cancer Medicine Research Programme, Section of Translational Medical Sciences, School of Medicine and Dentistry, University of Aberdeen, Foresterhill, Aberdeen,... 57Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. Marjanka K. Schmidt, Frans Hogervorst, Richard van Hien, Sten Cornelissen, Annegien Broeks, and Lizet van der Kolk, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital; Muriel A. Adank, Hanne Meijers, and Quinten Waisfisz, VU University Medical Center, Amsterdam; Antoinette Hollestelle, Mieke Schutte, Maartje Hooning, and Caroline Seynaeve, Erasmus MC Cancer Institute; Ans van den Ouweland, Erasmus University Medical Center, Rotterdam; Rob A.E.M. Tollenaar, Leiden University Medical Center,... From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Poznań; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Biała; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens... From the Drug Development Unit, Royal Marsden National Health Service Foundation Trust; The Institute of Cancer Research, Sutton, Surrey; Institute of Genetics and Molecular Medicine, University of Edinburgh Cancer Research, Edinburgh; the Breakthrough Breast Cancer Research Unit at King's College London, Guy's Campus; the Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London; AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom; the Netherlands Cancer... Department of Genetics and Pathology; Pomeranian Medical University; Szczecin Poland Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland. 51Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. Authors' Affiliations: 1Women's College Research Institute; 2Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, 3Department of Medicine, University of Toronto; 4Toronto-Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada; 5Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland; 6Department of Preventive Medicine and Public Health, Creighton University School of Medicine, Omaha, Nebraska; 7BC Cancer Agency, Vancouver, British Columbia, Canada; 8City of Hope National Medical Center, Duarte, California; 9Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University; 10Epidemiology Research Unit, Research Center of the University of Montreal Hospital Centre (CRCHUM), Montreal, Quebec, Canada; 11Beth Israel Deaconess Hospital, Boston, Massachusetts; 12London Regional Cancer Program, London, Ontario, Canada; 13Division of Human Genetics, The Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, Ohio; 14Gynecology O Mohammad Movahedi, Beheshti University of Medical Sciences, Tehran, Iran; Mohammad Movahedi and D. Timothy Bishop, University of Leeds, Leeds; Diana Eccles, University of Southampton, Southampton; D. Gareth Evans, St Mary's Hospital, Manchester; Eamonn R. Maher, University of Birmingham, Birmingham; Malcolm G. Dunlop, Western General Hospital, Edinburgh; Shirley V. Hodgson, St George's Hospital; Lucy Side, University College London; Huw J.W. Thomas, St Mark's Hospital, Imperial College, London; Patrick J... International Hereditary Cancer Centre, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland, International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland 20Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. 3Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland. 13Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Departments of Genetics and Pathology Pomeranian Medical University Szczecin Poland and the Genetics Workstream of the Schizophrenia Treatment Resistance and Therapeutic Advances (STRATA) Consortium and the Schizophrenia Working Group of the Psychiatric Genomics Consortium (PGC) Department of Genetics and Pathology, Pomeranian Medical University, Szczecin 70-204, Poland 1Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Department of Clinical Biochemistry and 2Center of Oncology, Department of Clinical Oncology, Bydgoszcz, Poland; 3International Hereditary Cancer Center, Department of Genetics and Pathology, Szczecin, Poland; and 4Nofer Institute of Occupational Medicine, Department of Toxicology and Carcinogenesis, Lodz, Poland |
Incoming Links
Total number of triples: 388.